- Home
- SANA vs HROW Comparison
SANA vs HROW Comparison
Compare SANA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANA | HROW |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SANA | HROW |
|---|---|---|
| Price | $4.45 | $49.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $7.83 | ★ $68.86 |
| AVG Volume (30 Days) | ★ 4.0M | 616.6K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $250,042,000.00 |
| Revenue This Year | N/A | $38.96 |
| Revenue Next Year | N/A | $43.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.83 |
| 52 Week Low | $1.26 | $20.85 |
| 52 Week High | $7.30 | $54.85 |
Technical Indicators
Market Signals| Indicator | SANA | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 51.27 |
| Support Level | $4.01 | $46.58 |
| Resistance Level | $4.91 | $54.85 |
| Average True Range (ATR) | 0.27 | 2.63 |
| MACD | -0.00 | -0.23 |
| Stochastic Oscillator | 52.04 | 36.60 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.